Complete Filing Data
NEUROONE MEDICAL TECHNOLOGIES Corp reported Net Income Loss of -$3.61 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean NEUROONE MEDICAL TECHNOLOGIES Corp did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$3.6M | -$12.3M | -$11.9M | -$10.0M | -$9.9M | -$13.6M | -$6.8M | -$47.8K | -$62.9K | -$36.2K | -$30.6K | -$14.0K | -$27.6K | -$6.0K |
| Cost of Revenue * | $4.0M | $2.4M | $1.5M | $242.0K | $275.9K | $0.00 | $2.1K | |||||||
| Revenue * | $9.1M | $3.5M | $2.0M | $171.2K | $178.1K | $0.00 | $0.00 | $773.00 | $1.2K | $921.00 | $5.4K | $1.2K | ||
| Operating Expenses | $12.4M | $13.0M | $13.9M | $11.9M | $10.2M | $6.8M | $5.8M | $32.6K | $30.9K | $36.7K | $26.3K | $14.7K | $30.7K | $7.2K |
| Operating Income Loss | -$4.2M | -$11.9M | -$12.0M | -$10.0M | -$10.2M | -$4.9M | -$5.8M | -$32.6K | -$30.9K | -$35.9K | -$25.1K | |||
| General And Administrative Expense | $6.3M | $4.8M | $4.3M | $32.6K | $30.9K | $36.7K | $26.3K | $14.7K | $30.7K | $7.2K | ||||
| Research And Development Expense | $5.0M | $5.1M | $6.9M | $4.9M | $3.9M | $2.1M | $1.5M | |||||||
| Gross Profit | $5.1M | $1.1M | $456.5K | -$70.8K | -$97.7K | $921.00 | $3.3K | $1.2K | ||||||
| Interest Income Expense Net | -$3.1K | -$7.5M | -$284.6K | |||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$3.6M | -$12.3M | -$11.9M | -$10.0M | -$2.0M | |||||||||
| Interest Expense | $3.1K | $14.0K | $330.00 | -$227.00 | -$176.00 | |||||||||
| Income Loss From Continuing Operations | -$32.6K | -$30.9K | -$13.7K | -$27.4K | -$6.0K | |||||||||
| Selling General And Administrative Expense | $7.4M | $7.9M | $6.9M | $7.0M | $6.3M | |||||||||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -$32.6K | -$30.9K | -$36.2K | -$30.6K | ||||||||||
| Deferred Revenue | $1.5M | $73.4K | ||||||||||||
| Revenue From Collaboration | $1.5M | $1.9M | $64.8K | $1.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 | Q4 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$1.4M | -$1.5M | -$2.3M | $1.8M | -$2.8M | -$2.9M | -$3.3M | -$3.5M | -$3.5M | -$1.7M | -$2.8M | -$3.1M | -$2.8M | -$3.0M | -$2.4M | -$2.0M | -$7.1M | -$1.3M | -$4.6M | -$1.9M | -$2.2M | -$1.4M | -$1.3M | -$1.4M | -$1.6M | -$944.4K | -$1.3M | -$729.6K | -$12.2K | -$24.7K | -$9.0K | -$10.1K | -$22.1K | -$11.6K | -$6.1K | -$16.0K | -$4.2K | -$5.1K | -$19.1K | -$3.3K | -$4.8K | -$2.4K | -$5.6K | -$4.2K | -$1.2K | -$6.7K | -$5.2K | -$2.8K | |
| Cost of Revenue * | $1.3M | $781.2K | $615.5K | $1.3M | $543.9K | $986.9K | $711.3K | $386.2K | $434.7K | $126.9K | $38.5K | $72.8K | $46.8K | $61.9K | $39.4K | $109.1K | |||||||||||||||||||||||||||||||||
| Revenue * | $2.9M | $1.7M | $1.4M | $3.3M | $825.8K | $1.4M | $977.6K | $629.9K | $466.2K | $114.6K | $32.0K | $36.6K | $33.7K | $40.1K | $18.2K | $71.5K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $113.00 | $139.00 | $303.00 | $165.00 | $252.00 | $451.00 | $406.00 | $23.00 | $147.00 | $812.00 | $3.1K | |||||||||||||||
| Operating Expenses | $3.3M | $2.8M | $3.5M | $3.2M | $3.1M | $3.3M | $3.7M | $3.8M | $3.5M | $3.2M | $2.8M | $3.0M | $2.8M | $3.0M | $2.4M | $2.1M | $1.6M | $1.4M | $1.8M | $1.9M | $1.5M | $1.1M | $1.2M | $1.1M | $773.8K | $893.8K | $888.7K | $516.1K | $8.6K | $14.1K | $4.4K | $2.6K | $18.7K | $9.8K | $6.3K | $16.3K | $4.1K | $5.0K | $15.2K | $3.4K | $4.8K | $2.7K | $5.7K | $4.9K | $2.4K | $9.7K | $5.5K | ||
| Operating Income Loss | -$1.7M | -$1.9M | -$2.7M | $1.7M | -$2.8M | -$2.9M | -$3.4M | -$3.5M | -$3.5M | -$1.8M | -$2.8M | -$3.1M | -$2.8M | -$3.0M | -$2.4M | -$2.1M | -$1.6M | -$1.4M | -$1.8M | -$1.9M | -$1.5M | -$1.1M | -$1.2M | -$1.1M | -$773.8K | -$893.8K | -$888.7K | -$516.1K | -$8.6K | -$14.1K | -$4.4K | -$2.6K | -$18.7K | -$1.8K | -$6.1K | -$16.0K | -$3.9K | -$4.7K | -$14.8K | -$3.0K | |||||||||
| General And Administrative Expense | $1.8M | $1.7M | $2.1M | $1.3M | $1.2M | $1.1M | $1.0M | $1.3M | $1.4M | $1.1M | $866.7K | $946.7K | $992.4K | $538.9K | $732.0K | $444.0K | $5.7K | $14.1K | $4.4K | $2.6K | $18.7K | $9.7K | $6.3K | $16.3K | $4.1K | $5.0K | $15.2K | $3.4K | $4.8K | $2.7K | $5.7K | $4.9K | $2.4K | $9.7K | $5.5K | ||||||||||||||
| Research And Development Expense | $1.4M | $1.2M | $1.5M | $1.2M | $1.2M | $1.3M | $1.5M | $1.9M | $1.7M | $1.6M | $1.2M | $1.2M | $1.1M | $901.1K | $1.1M | $934.2K | $447.2K | $342.1K | $501.8K | $422.8K | $436.3K | $209.2K | $225.5K | $105.0K | $234.9K | $156.7K | $72.0K | ||||||||||||||||||||||
| Gross Profit | $1.6M | $914.8K | $771.1K | $1.9M | $281.9K | $390.4K | $266.3K | $243.7K | $31.5K | -$12.3K | -$6.4K | -$36.2K | -$13.1K | -$21.8K | -$21.1K | -$37.7K | $139.00 | $303.00 | $165.00 | $252.00 | $451.00 | $406.00 | $23.00 | $391.00 | $147.00 | $812.00 | $1.2K | $3.1K | |||||||||||||||||||||
| Interest Income Expense Net | -$3.1K | -$4.7M | -$2.7M | -$20.5K | -$264.0K | -$304.4K | -$193.0K | -$338.1K | -$515.4K | -$350.0K | -$213.6K | -$3.6K | $0.00 | $42.00 | |||||||||||||||||||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$1.4M | -$1.5M | -$2.3M | $1.8M | -$2.8M | -$2.9M | -$3.3M | -$3.5M | -$3.5M | -$1.7M | -$2.8M | -$3.1M | -$2.8M | -$3.0M | -$2.4M | -$2.0M | -$7.1M | -$1.3M | -$4.6M | -$1.9M | -$2.2M | -$1.4M | |||||||||||||||||||||||||||
| Interest Expense | $4.3K | $4.0K | $3.7K | $11.6K | -$401.00 | -$327.00 | -$323.00 | -$49.00 | -$65.00 | -$55.00 | -$52.00 | -$38.00 | -$30.00 | ||||||||||||||||||||||||||||||||||||
| Income Loss From Continuing Operations | -$23.6K | -$8.8K | -$5.7K | -$14.1K | -$4.4K | -$2.6K | -$18.6K | -$3.0K | -$4.7K | -$2.3K | -$5.5K | -$4.1K | -$1.2K | -$6.7K | -$5.2K | ||||||||||||||||||||||||||||||||||
| Selling General And Administrative Expense | $1.9M | $1.6M | $1.9M | $2.0M | $1.9M | $2.0M | $2.2M | $1.9M | $1.8M | $1.7M | $1.5M | $1.8M | $1.7M | $2.1M | |||||||||||||||||||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -$8.8K | -$5.7K | -$14.1K | -$4.4K | -$2.6K | -$18.6K | -$11.6K | -$6.1K | -$16.0K | -$4.2K | -$5.1K | -$19.1K | -$3.3K | ||||||||||||||||||||||||||||||||||||
| Deferred Revenue | $2.2K | $2.2K | $2.2K | $8.6K | $13.6K | $31.0K | $51.2K | ||||||||||||||||||||||||||||||||||||||||||
| Revenue From Collaboration | $1.5M | $6.4K | $17.5K | $20.1K | $22.3K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $6.2M | $9.6M | $6.6M | $2.1M | -$1.2M | -$4.4M | -$5.0M | -$266.2K | -$81.5K | -$35.4K | -$30.3K | -$17.2K | $3.3K | -$4.3K | $1.2K | ||
| Liabilities Current | $2.2M | $1.8M | $3.1M | $1.2M | $2.4M | $1.8M | $3.8M | $677.2K | $83.3K | $35.6K | $30.8K | $4.6K | $3.0K | ||||
| Liabilities And Stockholders Equity | $5.4M | $8.1M | $12.8M | $7.9M | $4.8M | $532.6K | $218.7K | $756.9K | $1.8K | $205.00 | $525.00 | $13.9K | $9.1K | ||||
| Liabilities | $4.5M | $1.8M | $3.2M | $1.4M | $2.7M | $1.8M | $4.6M | $1.0M | $83.3K | $35.6K | $30.8K | $17.1K | $13.5K | ||||
| Assets | $5.4M | $8.1M | $12.8M | $7.9M | $4.8M | $532.6K | $218.7K | $756.9K | $1.8K | $205.00 | $525.00 | $13.9K | $9.1K | ||||
| Common Stock Value | $30.8K | $23.9K | $16.2K | $12.0K | $22.2K | $13.5K | $9.7K | $31.00 | $5.1K | $5.1K | $5.1K | $4.5K | |||||
| Assets Current | $4.6M | $7.3M | $12.2M | $7.3M | $4.2M | $301.8K | $18.6K | $576.0K | $205.00 | $525.00 | $13.9K | $9.1K | |||||
| Cash And Cash Equivalents At Carrying Value | $1.5M | $5.3M | $8.2M | $6.9M | $260.7K | $13.3K | $26.5K | ||||||||||
| Retained Earnings Accumulated Deficit | -$75.0M | -$62.7M | -$50.8M | -$40.8M | -$30.9M | -$17.2M | -$10.5M | -$266.4K | -$180.0K | -$117.2K | |||||||
| Cash | $1.5M | $5.3M | $8.2M | $6.9M | $260.7K | $13.3K | $26.5K | ||||||||||
| Cash Period Increase Decrease | $247.5K | $0.00 | -$205.00 | -$320.00 | -$593.00 | $4.7K | $7.9K | ||||||||||
| Intangible Assets Net Excluding Goodwill | $67.3K | $89.6K | $111.9K | $134.2K | $156.5K | $178.8K | $200.1K | $180.9K | |||||||||
| Accounts Payable Current | $1.0M | $685.1K | $927.7K | $528.8K | $762.5K | $1.2M | $221.2K | $10.9K | $10.0K | ||||||||
| Accrued Liabilities Current | $1.1M | $715.8K | $644.2K | $512.8K | $617.7K | $1.6M | $264.3K | $0.00 | $3.0K | ||||||||
| Property Plant And Equipment Net | $416.8K | $525.8K | $353.6K | $223.3K | $166.0K | $52.0K | |||||||||||
| Net Change In Fair Value Of Warrant Liability And Premium Conversion Derivative | -$129.8K | ||||||||||||||||
| Convertible Notes Payable Current | $1.0M | $1.4M | $0.00 | $6.0K | |||||||||||||
| Operating Lease Right Of Use Asset | $254.9K | $169.1K | $181.4K | $288.9K | $282.2K | ||||||||||||
| Operating Lease Liability Noncurrent | $194.4K | $55.3K | $119.6K | $202.9K | $254.3K | ||||||||||||
| Non Cash Interest On Short Term And Convertible Promissory Notes | $5.6M | $51.3K | |||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $5.1M | -$3.9M | -$2.8M | $1.3M | $2.9M | $3.8M | $247.5K | ||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $5.3M | $8.2M | |||||||||||||||
| Gains Losses On Extinguishment Of Debt | -$2.0M | -$553.4K | |||||||||||||||
| Revaluation Of Warrant Liability | $18.6K | ||||||||||||||||
| Revaluation Of Premium Debt Conversion Derivative | $111.2K | ||||||||||||||||
| Inventory Net | $2.6M | $1.7M | $704.5K | $98.3K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q1 2011 | Q4 2010 | Q4 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $6.4M | $7.1M | $8.2M | $1.1M | $2.9M | $822.0K | $3.0M | $3.9M | $4.4M | $3.9M | $5.5M | $8.2M | $10.6M | $13.1M | $15.9M | $8.9M | $10.9M | $1.4M | -$3.9M | -$5.2M | -$4.6M | -$273.4K | $444.6K | -$1.2M | -$7.3M | -$6.4M | -$3.5M | -$128.5K | -$104.9K | -$105.2K | -$99.5K | -$84.7K | -$63.9K | -$57.1K | -$35.0K | -$25.5K | -$19.4K | -$3.4K | -$28.3K | -$25.7K | -$17.5K | -$15.8K | -$11.2K | -$8.9K | -$3.3K | -$12.2K | -$4.3K | -$1.2K | |||||||
| Liabilities Current | $1.3M | $2.3M | $1.4M | $1.8M | $1.6M | $1.7M | $1.5M | $1.4M | $1.7M | $1.6M | $1.3M | $814.5K | $810.2K | $1.1M | $746.9K | $750.4K | $6.2M | $8.0M | $6.3M | $7.0M | $1.8M | $2.1M | $4.7M | $3.3M | $5.0M | $3.9M | $3.0M | $128.5K | $104.9K | $109.5K | $103.8K | $86.6K | $64.1K | $57.5K | $35.2K | $26.1K | $20.1K | $3.9K | $28.9K | $27.0K | $22.7K | $18.4K | $4.8K | $4.7K | $4.7K | $4.6K | |||||||||
| Liabilities And Stockholders Equity | $8.6M | $10.8M | $10.8M | $4.5M | $6.5M | $4.9M | $5.4M | $5.8M | $5.8M | $7.2M | $9.7M | $11.6M | $14.1M | $17.2M | $9.8M | $11.9M | $7.9M | $4.5M | $1.4M | $2.7M | $1.5M | $2.6M | $577.5K | $229.7K | $243.8K | $250.0K | $267.8K | $0.00 | $0.00 | $4.3K | $4.3K | $1.8K | $201.00 | $371.00 | $195.00 | $599.00 | $680.00 | $500.00 | $608.00 | $1.3K | $5.1K | $1.1K | $1.5K | $6.0K | $8.3K | $4.9K | |||||||||
| Liabilities | $2.2M | $3.7M | $2.6M | $3.3M | $3.6M | $1.9M | $1.5M | $1.4M | $1.8M | $1.7M | $1.5M | $952.5K | $966.3K | $1.2M | $953.8K | $1.1M | $6.5M | $8.4M | $6.6M | $7.3M | $1.8M | $2.1M | $5.5M | $7.5M | $6.6M | $5.3M | $3.8M | $128.5K | $104.9K | $109.5K | $103.8K | $86.6K | $64.1K | $57.5K | $35.2K | $26.1K | $20.1K | $3.9K | $28.9K | $27.0K | $22.7K | $18.4K | $17.3K | $17.2K | $17.2K | $17.1K | |||||||||
| Assets | $8.6M | $10.8M | $10.8M | $4.5M | $6.5M | $4.9M | $5.4M | $5.8M | $5.8M | $7.2M | $9.7M | $11.6M | $14.1M | $17.2M | $9.8M | $11.9M | $7.9M | $4.5M | $1.4M | $2.7M | $1.5M | $2.6M | $577.5K | $229.7K | $243.8K | $250.0K | $267.8K | $0.00 | $0.00 | $4.3K | $4.3K | $1.8K | $201.00 | $371.00 | $195.00 | $599.00 | $680.00 | $500.00 | $608.00 | $1.3K | $5.1K | $1.1K | $1.5K | $6.0K | $8.3K | $4.9K | |||||||||
| Common Stock Value | $50.4K | $50.0K | $49.8K | $31.4K | $30.8K | $27.8K | $26.3K | $24.8K | $17.9K | $16.9K | $16.2K | $16.2K | $40.0K | $40.0K | $35.8K | $35.7K | $23.1K | $18.2K | $14.0K | $13.7K | $13.4K | $12.9K | $10.0K | $8.0K | $7.9K | $7.9K | $7.9K | $5.1K | $5.1K | $5.1K | $5.1K | $5.1K | $5.1K | $5.1K | $5.1K | $5.1K | $5.1K | $5.1K | $5.1K | $5.1K | $5.1K | $5.1K | $5.1K | $5.1K | $4.6K | ||||||||||
| Assets Current | $8.1M | $10.2M | $10.2M | $3.8M | $5.7M | $4.1M | $4.7M | $5.1M | $4.9M | $6.4M | $9.0M | $10.9M | $13.4M | $16.6M | $9.3M | $11.4M | $7.3M | $3.9M | $828.5K | $2.1M | $1.3M | $2.4M | $382.8K | $23.2K | $32.3K | $33.6K | $77.2K | $1.8K | $1.8K | $201.00 | $371.00 | $195.00 | $599.00 | $680.00 | $500.00 | $608.00 | $1.3K | $5.1K | $1.1K | $1.5K | $6.0K | $8.3K | $4.9K | ||||||||||||
| Cash And Cash Equivalents At Carrying Value | $3.6M | $6.6M | $8.0M | $1.3M | $1.1M | $1.6M | $2.4M | $2.7M | $3.1M | $3.6M | $4.7M | $10.2M | $12.9M | $16.2M | $9.0M | $11.3M | $7.1M | $4.0M | $3.8M | $747.2K | $2.0M | $1.2M | $2.3M | $350.6K | $22.6K | $25.2K | $70.0K | ||||||||||||||||||||||||||||
| Retained Earnings Accumulated Deficit | -$80.0M | -$78.6M | -$77.0M | -$75.5M | -$73.2M | -$71.7M | -$68.9M | -$66.0M | -$59.6M | -$56.1M | -$52.6M | -$49.5M | -$46.7M | -$43.6M | -$38.2M | -$35.2M | -$32.8M | -$30.3M | -$23.2M | -$21.9M | -$15.9M | -$14.0M | -$11.8M | -$7.9M | -$6.7M | -$5.3M | -$3.7M | -$179.1K | -$155.5K | -$219.4K | -$213.7K | -$189.0K | -$161.0K | -$150.9K | |||||||||||||||||||||
| Cash | $3.6M | $6.6M | $8.0M | $1.3M | $1.1M | $1.6M | $2.4M | $2.7M | $3.1M | $3.6M | $4.7M | $10.2M | $12.9M | $16.2M | $9.0M | $11.3M | $7.1M | $4.0M | $3.8M | $747.2K | $2.0M | $1.2M | $2.3M | $350.6K | $22.6K | $25.2K | $70.0K | ||||||||||||||||||||||||||||
| Cash Period Increase Decrease | $1.8M | $337.3K | -$43.6K | $0.00 | $0.00 | -$10.00 | -$25.00 | $4.0K | -$5.5K | -$6.7K | |||||||||||||||||||||||||||||||||||||||||||||
| Intangible Assets Net Excluding Goodwill | $39.4K | $44.9K | $50.5K | $56.1K | $61.7K | $72.8K | $78.4K | $84.0K | $95.2K | $100.7K | $106.3K | $117.5K | $123.0K | $128.6K | $139.8K | $145.4K | $150.9K | $162.1K | $167.7K | $173.3K | $184.1K | $189.5K | $194.8K | $206.5K | $211.4K | $216.4K | $190.6K | ||||||||||||||||||||||||||||
| Accounts Payable Current | $552.3K | $1.0M | $467.7K | $910.8K | $744.5K | $759.3K | $780.8K | $760.0K | $958.8K | $953.4K | $861.6K | $325.0K | $446.0K | $703.7K | $296.4K | $345.8K | $519.5K | $911.5K | $1.1M | $1.1M | $868.5K | $687.9K | $470.3K | $82.2K | $41.7K | $27.8K | $22.4K | $21.3K | $21.1K | $15.6K | $8.1K | $8.8K | $3.1K | ||||||||||||||||||||||
| Accrued Liabilities Current | $826.4K | $1.2M | $931.7K | $759.6K | $623.2K | $789.1K | $596.9K | $473.1K | $487.2K | $362.0K | $356.4K | $436.8K | $373.5K | $611.9K | $397.5K | $291.9K | $636.4K | $941.0K | $1.2M | $1.7M | $1.5M | $1.5M | $1.0M | $916.7K | $1.5K | $169.00 | $11.7K | $3.9K | |||||||||||||||||||||||||||
| Property Plant And Equipment Net | $244.9K | $259.2K | $314.6K | $334.9K | $381.7K | $472.5K | $496.0K | $505.2K | $586.9K | $522.8K | $334.8K | $315.3K | $287.0K | $216.6K | $156.4K | $161.1K | $152.9K | $101.0K | $84.9K | $68.2K | $53.3K | ||||||||||||||||||||||||||||||||||
| Net Change In Fair Value Of Warrant Liability And Premium Conversion Derivative | -$116.8K | -$13.0K | $215.6K | $120.0K | -$162.5K | -$55.6K | $32.00 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Convertible Notes Payable Current | $6.7M | $4.9M | $5.2M | $1.7M | $1.1M | $2.2M | $1.5M | $17.6K | $13.6K | $9.3K | $5.5K | $1.8K | |||||||||||||||||||||||||||||||||||||||||||
| Operating Lease Right Of Use Asset | $226.3K | $255.2K | $283.6K | $311.7K | $339.3K | $281.8K | $110.7K | $140.2K | $197.3K | $225.0K | $252.1K | $208.9K | $236.0K | $262.7K | $241.2K | $255.4K | $268.9K | $295.3K | $308.1K | $325.2K | |||||||||||||||||||||||||||||||||||
| Operating Lease Liability Noncurrent | $110.4K | $143.1K | $175.3K | $207.0K | $237.4K | $209.9K | $21.0K | $88.9K | $121.9K | $153.7K | $138.0K | $156.0K | $173.3K | $207.0K | $223.4K | $239.0K | $269.4K | $284.2K | $298.3K | ||||||||||||||||||||||||||||||||||||
| Non Cash Interest On Short Term And Convertible Promissory Notes | $1.8M | $30.8K | $39.5K | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$3.0M | -$325.7K | -$2.6M | -$3.5M | $9.3M | $3.1M | $1.8M | ||||||||||||||||||||||||||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $3.6M | $6.6M | $8.0M | $1.3M | $1.1M | $1.5M | $1.6M | $2.4M | $2.7M | $3.1M | $3.6M | $4.7M | $10.2M | $12.9M | $6.9M | $9.0M | $11.3M | $4.0M | |||||||||||||||||||||||||||||||||||||
| Gains Losses On Extinguishment Of Debt | -$2.0M | -$553.4K | -$186.2K | -$350.9K | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Revaluation Of Warrant Liability | $6.7K | -$124.0K | $270.7K | -$215.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Revaluation Of Premium Debt Conversion Derivative | $6.3K | $4.0K | -$108.2K | $183.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventory Net | $1.7M | $2.2M | $1.9M | $1.8M | $1.9M | $1.8M | $1.3M | $1.6M | $1.5M | $1.2M | $903.6K | $454.3K | $221.9K | $229.1K | $52.2K | $13.8K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $1.3M | $1.3M | $1.1M | $947.2K | $324.2K | |||||||||
| Financing Cash Flow * | $8.0M | $7.3M | $7.4M | $12.0M | $11.5M | $7.3M | $5.8M | $21.1K | $30.0K | $25.9K | $24.5K | $1.0K | $32.2K | $13.0K |
| Investing Cash Flow * | -$81.7K | -$120.2K | $2.6M | -$3.2M | -$67.1K | -$122.4K | -$123.4K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Operating Cash Flow * | -$2.8M | -$11.0M | -$12.9M | -$7.5M | -$8.6M | -$3.4M | -$5.4M | -$21.1K | -$30.2K | -$26.2K | -$25.1K | -$13.7K | -$27.4K | -$5.1K |
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $1.3M | $1.1M | $947.2K | $1.8M | $798.2K | $324.2K | ||||||||
| Increase Decrease In Accounts Payable | $240.0K | $67.0K | -$247.2K | $515.4K | -$350.3K | -$269.6K | $770.6K | $11.5K | -$2.1K | |||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$32.9K | $145.5K | $8.3K | $77.6K | $35.6K | |||||||||
| Proceeds From Convertible Debt | $8.4M | $3.2K | $4.0K | |||||||||||
| Increase Decrease In Accrued Liabilities | $1.4M | -$7.5K | -$82.4K | -$836.9K | ||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $3.7K | $13.0K | ||||||||||||
| Payments To Acquire Property Plant And Equipment | $81.7K | $120.2K | $384.1K | $275.2K | $67.1K | $122.4K | $58.4K | |||||||
| Increase Decrease In Inventories | -$398.3K | $908.5K | $1.0M | $606.3K | $98.3K | |||||||||
| Increase Decrease In Accounts Receivable | $1.1M | $176.6K | -$33.2K | -$15.1K | $48.3K | |||||||||
| Proceeds From Issuance Of Warrants Associated With Convertible Promissory Notes |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q4 2018 | Q1 2018 | Q4 2017 | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share-Based Compensation * | $359.3K | $339.2K | $308.6K | $296.4K | $300.2K | $255.5K | $119.0K | $254.4K | ||||||||||||||||||||
| Financing Cash Flow * | $147.8K | -$509.3K | $1.2M | -$15.7K | $12.0M | $5.0M | $3.0M | $1.0M | $590.0K | $646.6K | $315.1K | $0.00 | $19.6K | $7.0K | ||||||||||||||
| Investing Cash Flow * | -$40.8K | -$24.4K | -$37.1K | $15.1K | -$61.5K | -$10.3K | -$91.7K | $0.00 | $0.00 | $0.00 | ||||||||||||||||||
| Operating Cash Flow * | -$3.1M | $208.0K | -$3.8M | -$3.5M | -$2.7M | -$1.9M | -$1.2M | -$699.7K | -$591.3K | -$598.4K | -$350.9K | $0.00 | -$19.6K | -$25.00 | -$3.0K | -$5.5K | -$6.7K | |||||||||||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $250.2K | $339.2K | $338.6K | $356.9K | $308.6K | $296.4K | $237.6K | $300.2K | $255.5K | $232.7K | $203.1K | $878.9K | $326.4K | $245.8K | $104.0K | $88.8K | $463.1K | |||||||||||
| Increase Decrease In Accounts Payable | -$440.0K | -$14.9K | $79.5K | -$154.1K | $291.2K | -$243.0K | $6.7K | $278.7K | ||||||||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$21.8K | -$3.8K | -$74.9K | -$13.6K | $7.3K | $6.8K | $26.8K | |||||||||||||||||||||
| Proceeds From Convertible Debt | $3.2M | $236.1K | $328.4K | $192.4K | $5.7K | $12.0K | ||||||||||||||||||||||
| Increase Decrease In Accrued Liabilities | -$306.1K | -$317.5K | $111.3K | -$18.1K | $246.8K | $107.6K | ||||||||||||||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $278.7K | $171.1K | $5.5K | $4.7K | -$9.8K | $4.2K | $323.00 | |||||||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $40.8K | $24.4K | $37.1K | $11.5K | $61.5K | $10.3K | ||||||||||||||||||||||
| Increase Decrease In Inventories | -$560.7K | -$704.3K | -$118.0K | $199.0K | $130.8K | $13.8K | ||||||||||||||||||||||
| Increase Decrease In Accounts Receivable | $1.4M | $2.2M | $543.4K | $62.1K | -$23.7K | $71.5K | ||||||||||||||||||||||
| Proceeds From Issuance Of Warrants Associated With Convertible Promissory Notes | $238.9K | $336.6K | $182.7K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.09 | -$0.46 | -$0.65 | -$0.63 | -$0.93 | -$2.52 | -$0.57 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | $0.00 | -$0.01 | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 10.7M | 5.4M | 11.9M | 5.1M | 5.1M | 5.1M | 5.1M | |||||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Outstanding | 30.8M | 23.9M | 16.2M | 12.0M | 7.4M | 13.5M | 9.7M | 5.2M | 5.1M | 5.1M | 5.1M | 4.5M | ||||
| Common Stock Shares Issued | 30.8M | 23.9M | 16.2M | 12.0M | 7.4M | 13.5M | 9.7M | 5.2M | 5.1M | 5.1M | 5.1M | 4.5M | ||||
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 45.0M | 45.0M | 45.0M | 45.0M | 45.0M | ||||
| Weighted Average Number Of Shares Outstanding Basic | 40.2M | 26.8M | 18.1M | 16.0M | 10.7M | 5.1M | 4.6M | 4.3M | ||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 40.2M | 26.8M | 18.1M | 16.0M | 10.7M | |||||||||||
| Earnings Per Share Basic | $-0.09 | $-0.46 | $-0.65 | $-0.63 | $-0.93 | |||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q4 2011 | Q3 2011 | Q2 2011 | Q1 2011 | Q3 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.03 | -$0.03 | -$0.07 | $0.06 | -$0.10 | -$0.11 | -$0.14 | -$0.20 | -$0.21 | -$0.11 | -$0.17 | -$0.19 | -$0.18 | -$0.25 | -$0.21 | -$0.26 | -$1.33 | -$0.29 | -$0.34 | -$0.14 | -$0.20 | -$0.14 | -$0.16 | -$0.17 | -$0.21 | -$0.18 | -$0.22 | -$0.14 | -$0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 15.4M | 12.0M | 11.2M | 7.7M | 5.3M | 4.6M | 13.7M | 13.2M | 11.0M | 9.8M | 8.0M | 7.9M | 7.9M | 7.9M | 5.9M | 5.2M | 1.7M | 5.1M | 5.1M | 5.1M | 5.1M | 5.1M | 5.1M | 5.1M | 5.1M | 4.5M | 4.5M | 5.1M | ||||||||||||||||||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | ||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Common Stock Shares Outstanding | 50.4M | 50.0M | 49.8M | 31.4M | 30.8M | 27.8M | 26.3M | 24.8M | 17.9M | 16.9M | 16.2M | 16.2M | 16.2M | 16.2M | 12.0M | 11.9M | 23.1M | 18.2M | 14.0M | 13.7M | 13.4M | 12.9M | 10.0M | 8.0M | 7.9M | 7.9M | 7.9M | 5.1M | 5.1M | 5.1M | 5.1M | 5.1M | 5.1M | 5.1M | 5.1M | 5.1M | 5.1M | 5.1M | 5.1M | 5.1M | 5.1M | 4.5M | ||||||||
| Common Stock Shares Issued | 50.4M | 50.0M | 49.8M | 31.4M | 30.8M | 27.8M | 26.3M | 24.8M | 17.9M | 16.9M | 16.2M | 16.2M | 16.2M | 16.2M | 12.0M | 11.9M | 23.1M | 18.2M | 14.0M | 13.7M | 13.4M | 12.9M | 10.0M | 8.0M | 7.9M | 7.9M | 7.9M | 5.1M | 5.1M | 5.1M | 5.1M | 5.1M | 5.1M | 5.1M | 5.1M | 5.1M | 5.1M | 5.1M | 5.1M | 5.1M | 5.1M | 4.5M | ||||||||
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 45.0M | 45.0M | 45.0M | 45.0M | 45.0M | 45.0M | 45.0M | 45.0M | 45.0M | 45.0M | 45.0M | 45.0M | 45.0M | 45.0M | ||||||||
| Weighted Average Number Of Shares Outstanding Basic | 50.3M | 48.6M | 31.1M | 30.8M | 27.4M | 25.9M | 24.0M | 17.6M | 16.4M | 16.2M | 16.2M | 16.2M | 15.4M | 12.0M | 4.5M | 4.5M | 5.1M | 4.5M | 4.5M | 5.1M | 4.6M | 4.5M | 4.5M | 4.5M | ||||||||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 50.3M | 48.6M | 31.1M | 30.9M | 27.4M | 25.9M | 24.0M | 17.6M | 16.4M | 16.2M | 16.2M | 16.2M | 15.4M | 12.0M | 11.2M | |||||||||||||||||||||||||||||||||||
| Earnings Per Share Basic | $-0.03 | $-0.03 | $-0.07 | $0.06 | $-0.10 | $-0.11 | $-0.14 | $-0.20 | $-0.21 | $-0.11 | $-0.17 | $-0.19 | $-0.18 | $-0.25 | $-0.21 | |||||||||||||||||||||||||||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||||||||||||||||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2016 | FY2015 | FY2014 | FY2013 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $75.8M | $68.9M | $60.4M | $47.4M | $32.9M | $16.0M | $6.1M | $119.00 | $45.6K | $76.7K | $45.6K | $28.1K | ||
| Prepaid Expense Current | $216.5K | $263.7K | $296.6K | $244.0K | $118.6K | $41.0K | $5.4K | $53.8K | ||||||
| Adjustment For Amortization | $27.6K | |||||||||||||
| Conversion Derivative Related To Convertible Promissory Notes | ||||||||||||||
| Stock Issued During Period Value New Issues | $9.6M | $1.1M | $573.00 | $500.00 | ||||||||||
| Stock Issued During Period Value Issued For Services | $641.7K | $115.0K | ||||||||||||
| Development Stage Enterprise Deficit Accumulated During Development Stage | $80.9K | -$36.4K | -$8.8K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 | Q2 2013 | Q1 2013 | Q4 2012 | Q3 2012 | Q2 2012 | Q1 2012 | Q3 2011 | Q4 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $86.4M | $85.6M | $85.1M | $76.6M | $76.1M | $74.6M | $72.7M | $70.4M | $63.5M | $61.6M | $60.7M | $60.1M | $59.8M | $59.5M | $47.0M | $46.1M | $34.2M | $26.4M | $18.0M | $17.2M | $15.6M | $14.5M | $6.8M | $646.0K | $279.2K | $280.3K | $162.7K | $45.6K | $45.6K | $45.6K | $45.6K | $99.2K | $92.0K | $88.7K | $88.7K | $76.7K | $76.7K | $76.7K | $44.6K | $42.1K | $31.1K | $28.1K | $28.1K | $28.1K | $28.1K | $4.2K | ||
| Prepaid Expense Current | $154.5K | $141.4K | $233.4K | $208.1K | $278.8K | $370.7K | $325.5K | $296.6K | $315.1K | $137.5K | $188.4K | $81.0K | $125.9K | $80.2K | $81.3K | $47.8K | $51.9K | $80.0K | $32.2K | $619.00 | $7.1K | $7.1K | ||||||||||||||||||||||||||
| Adjustment For Amortization | $9.9K | $5.3K | $5.3K | $5.3K | $5.0K | $5.0K | $4.3K | $5.0K | ||||||||||||||||||||||||||||||||||||||||
| Conversion Derivative Related To Convertible Promissory Notes | $77.1K | $91.3K | $128.5K | $72.7K | ||||||||||||||||||||||||||||||||||||||||||||
| Stock Issued During Period Value New Issues | $9.2M | $414.0K | $2.1M | $1.3M | -$51.4K | -$183.4K | $13.4M | $601.6K | $1.0K | |||||||||||||||||||||||||||||||||||||||
| Stock Issued During Period Value Issued For Services | $241.2K | $153.6K | $124.6K | $115.0K | ||||||||||||||||||||||||||||||||||||||||||||
| Development Stage Enterprise Deficit Accumulated During Development Stage | $128.8K | $117.2K | $107.3K | $101.2K | $85.2K | -$77.9K | -$72.8K | -$53.7K | -$50.4K | -$49.0K | -$44.4K | -$42.0K | -$20.9K |
Most recent annual filing with the SEC: December 17, 2025
Data sourced from SEC EDGAR public filings as of August 4, 2026.